Provided By PR Newswire
Last update: Sep 5, 2024
Normalized EBITDA of BRL 33.7 million in Q2 2024 and BRL 56.8 million in H1 2024
Strict cost control led G&A as % of revenues to 14.5% in H1 2024 from 18.5% in H1 2023
Read more at prnewswire.comNASDAQ:ZENV (11/13/2025, 2:27:54 PM)
1.32
-0.01 (-0.75%)
Find more stocks in the Stock Screener


